CEFAZOLIN
Cefazolin for Injection, USP
Approved
Approval ID
c47c8d14-1eef-40f9-9d11-f0c300b1d4be
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 27, 2023
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CEFAZOLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-236
Application NumberANDA065303
Product Classification
M
Marketing Category
C73584
G
Generic Name
CEFAZOLIN SODIUM
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateSeptember 27, 2023
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 500 mg in 2.2 mL
Code: P380M0454Z
Classification: ACTIM
CEFAZOLIN SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63323-237
Application NumberANDA065303
Product Classification
M
Marketing Category
C73584
G
Generic Name
CEFAZOLIN SODIUM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 27, 2023
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 1 g in 3 mL
Code: P380M0454Z
Classification: ACTIM